Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunity.

Source:http://linkedlifedata.com/resource/pubmed/id/17617631

J. Immunol. 2007 Jul 15 179 2 1381-8

Download in:

View as

General Info

PMID
17617631